Discover and read the best of Twitter Threads about #DendriticCells
Most recents (2)
Did you know that some proteins can increase or *decrease* #CellMigration, depending on the cell type?
Check our review on how ion channels (#Pannexins) & #calciumsignaling regulate immune, non-immune & #cancer migration.
Hot from the press: readcube.com/articles/10.33… #SciComm
/1
Check our review on how ion channels (#Pannexins) & #calciumsignaling regulate immune, non-immune & #cancer migration.
Hot from the press: readcube.com/articles/10.33… #SciComm
/1
It all started when we wrote something with @palomi_rock
The intro was so good & had so much new data that we decided to make a 'short' review/update of pannexins in #immunecells, focus on cell migration.
But things got out of hand & we started to include more cell types 😅🤷🏽♂️
/2
The intro was so good & had so much new data that we decided to make a 'short' review/update of pannexins in #immunecells, focus on cell migration.
But things got out of hand & we started to include more cell types 😅🤷🏽♂️
/2
Then, @LpzLpz_Tami joined to help with migration of immune cells, such as #DendriticCells, #Tcells, #Neutrophils, and to do the beautiful figures @BioRender 😍
Next, @APalacio_s joined to bring a broader vision of migration's impact during neuroinflammation, senescence, etc
/3
Next, @APalacio_s joined to bring a broader vision of migration's impact during neuroinflammation, senescence, etc
/3
🎉CELEBRATION ALERT!! We reached 10K followers @NatureCancer - massive thank you to our wonderful community for the warm welcome! Given it is also 10 months of our online life, here are some of our best articles (although all are *fantastic*) #thread 1/n
#10atNatureCancer
#10atNatureCancer
January @NatureCancer: Nabel &co @SanofiUS develp #trispecific antibodies against CD3, CD28 and CD38, with preclinical efficacy and safety in humanized mice and NHPs 2/n
go.nature.com/30GlQyH
rdcu.be/b78Zr
#10atNatureCancer
go.nature.com/30GlQyH
rdcu.be/b78Zr
#10atNatureCancer
February @NatureCancer: Golub and Co @broadinstitute develop PRISM, a tool for non-oncology drug repurposing in #cancer 3/n
go.nature.com/36zCxQh
rdcu.be/b78ZE
#10atNatureCancer
go.nature.com/36zCxQh
rdcu.be/b78ZE
#10atNatureCancer
